Biomarker results from the AVADO phase 3 trial of first-line bevacizumab plus docetaxel for HER2-negative metastatic breast cancer
MILES, D. W, DE HAAS, S. L, SCHERER, S. J, DIRIX, L. Y, ROMIEU, G, CHAN, A, PIVOT, X, TOMCZAK, P, PROVENCHER, L, CORTES, J, DELMAR, P. R
Published in British journal of cancer (19.03.2013)
Published in British journal of cancer (19.03.2013)
Get full text
Journal Article
Pharmacokinetics, pharmacodynamics and the pharmacokinetic/ pharmacodynamic relationship of zolpidem in healthy subjects
de Haas, S L, Schoemaker, R C, van Gerven, J M A, Hoever, P, Cohen, A F, Dingemanse, J
Published in Journal of psychopharmacology (Oxford) (01.11.2010)
Published in Journal of psychopharmacology (Oxford) (01.11.2010)
Get more information
Journal Article
Trastuzumab emtansine (T-DM1) plus docetaxel with or without pertuzumab in patients with HER2-positive locally advanced or metastatic breast cancer: results from a phase Ib/IIa study
Martin, M., Fumoleau, P., Dewar, J.A., Albanell, J., Limentani, S.A., Campone, M., Chang, J.C., Patre, M., Strasak, A., de Haas, S.L., Xu, J., Garcia-Saenz, J.A.
Published in Annals of oncology (01.07.2016)
Published in Annals of oncology (01.07.2016)
Get full text
Journal Article
Local nitric oxide release does not affect tachyphylaxis to angiotensin II in dorsal hand veins in man in the presence of prostaglandin synthesis inhibition
de Haas, S. L., Wilkinson, I. B., Boyd, J. L., Webb, D. J.
Published in British journal of clinical pharmacology (01.02.2002)
Published in British journal of clinical pharmacology (01.02.2002)
Get full text
Journal Article
The effects of TPA023, a GABAAα2,3 subtype-selective partial agonist, on essential tremor in comparison to alcohol
de Haas, S L, Zoethout, R W M, Van Dyck, K, De Smet, M, Rosen, L B, Murphy, M G, Gottesdiener, K M, Schoemaker, R C, Cohen, A F, van Gerven, J M A
Published in Journal of psychopharmacology (Oxford) (01.02.2012)
Published in Journal of psychopharmacology (Oxford) (01.02.2012)
Get more information
Journal Article
MK-0873, a PDE4 inhibitor, does not influence the pharmacokinetics of theophylline in healthy male volunteers
Boot, J.D, De Haas, S.L, Van Gerven, J.M.A, De Smet, M, Leathem, T, Wagner, J, Denker, A, Miller, D, Van Doorn, M.B.A, Schoemaker, R.C, Cohen, A.F, Diamant, Z
Published in Pulmonary pharmacology & therapeutics (01.01.2008)
Published in Pulmonary pharmacology & therapeutics (01.01.2008)
Get full text
Journal Article
Trastuzumab emtansine (T-DM1) plus docetaxel with or without pertuzumab in patients with HER2-positive locally advanced or metastatic breast cancer: results from a phase Ib/IIa study super()
Martin, M, Fumoleau, P, Dewar, J A, Albanell, J, Limentani, S A, Campone, M, Chang, J C, Patre, M, Strasak, A, de Haas, S L, Xu, J, Garcia-Saenz, J A
Published in Annals of oncology (01.07.2016)
Published in Annals of oncology (01.07.2016)
Get full text
Journal Article
Pharmacodynamic and pharmacokinetic effects of TPA023, a GABA(A) alpha(2,3) subtype-selective agonist, compared to lorazepam and placebo in healthy volunteers
de Haas, S L, de Visser, S J, van der Post, J P, de Smet, M, Schoemaker, R C, Rijnbeek, B, Cohen, A F, Vega, J M, Agrawal, N G B, Goel, T V, Simpson, R C, Pearson, L K, Li, S, Hesney, M, Murphy, M G, van Gerven, J M A
Published in Journal of psychopharmacology (Oxford) (01.06.2007)
Published in Journal of psychopharmacology (Oxford) (01.06.2007)
Get more information
Journal Article
Abstract P6-07-09: Biomarker analysis from the neoadjuvant KRISTINE study in HER2-positive early breast cancer (EBC)
de Haas, SL, Hurvitz, SA, Martin, M, Kiermaier, A, Lewis Phillips, G, Xu, J, Helms, H-J, Slamon, D, Press, MF
Published in Cancer research (Chicago, Ill.) (15.02.2017)
Published in Cancer research (Chicago, Ill.) (15.02.2017)
Get full text
Journal Article
Abstract PD3-06: Association of intrinsic subtypes with pathological complete response (pCR) in the KRISTINE neoadjuvant phase 3 clinical trial in HER2-positive early breast cancer (EBC)
Prat, A, Slamon, D, Hurvitz, SA, Press, MF, Lewis Phillips, G, Lopez Valverde, V, Kiermaier, A, Helms, H-J, Martin, M, de Haas, SL
Published in Cancer research (Chicago, Ill.) (15.02.2018)
Published in Cancer research (Chicago, Ill.) (15.02.2018)
Get full text
Journal Article
Abstract P1-09-05: The role of immune and apoptosis markers for prediction of pCR in the WSG-ADAPT HER2+/HR+ phase II trial evaluating 12-weeks of neoadjuvant TDM1 ± endocrine therapy (ET) versus T + ET in HER2-positive hormone-receptor-positive early breast cancer (EBC)
Harbeck, N, Nitz, UA, Matthias, C, Kates, R, Braun, M, Kümmel, S, Schumacher, C, Potenberg, J, Kraemer, S, Kleine-Tebbe, A, Augustin, D, Aktas, B, Forstbauer, H, Tio, J, Liedtke, C, Grischke, E-M, de Haas, SL, Deurloo, R, Schumacher, J, Wuerstlein, R, Kreipe, HH, Gluz, O
Published in Cancer research (Chicago, Ill.) (15.02.2017)
Published in Cancer research (Chicago, Ill.) (15.02.2017)
Get full text
Journal Article
The pharmacokinetic and pharmacodynamic effects of SL65.1498, a GABA-A alpha2,3 selective agonist, in comparison with lorazepam in healthy volunteers
de Haas, S L, Franson, K L, Schmitt, J A J, Cohen, A F, Fau, J B, Dubruc, C, van Gerven, J M A
Published in Journal of psychopharmacology (Oxford) (01.08.2009)
Published in Journal of psychopharmacology (Oxford) (01.08.2009)
Get more information
Journal Article
Abstract S5-03: Final analysis of WSG-ADAPT HER2+/HR+ phase II trial: Efficacy, safety, and predictive markers for 12-weeks of neoadjuvant TDM1 with or without endocrine therapy versus trastuzumab+endocrine therapy in HER2-positive hormone-receptor-positive early breast cancer
Harbeck, N, Gluz, O, Christgen, M, Braun, M, Kuemmel, S, Schumacher, C, Potenberg, J, Kraemer, S, Kleine-Tebbe, A, Augustin, D, Aktas, B, Forstbauer, H, Tio, J, Liedtke, C, Kates, RE, Wuerstlein, R, de Haas, SL, Kiermaier, A, Kreipe, HH, Nitz, U
Published in Cancer research (Chicago, Ill.) (15.02.2016)
Published in Cancer research (Chicago, Ill.) (15.02.2016)
Get full text
Journal Article
Pharmacodynamic and pharmacokinetic effects of MK-0343, a GABA(A) alpha2,3 subtype selective agonist, compared to lorazepam and placebo in healthy male volunteers
de Haas, S L, de Visser, S J, van der Post, J P, Schoemaker, R C, van Dyck, K, Murphy, M G, de Smet, M, Vessey, L K, Ramakrishnan, R, Xue, L, Cohen, A F, van Gerven, J M A
Published in Journal of psychopharmacology (Oxford) (01.01.2008)
Get more information
Published in Journal of psychopharmacology (Oxford) (01.01.2008)
Journal Article
Abstract P2-16-04: Plasma Biomarker Analyses in the AVADO Phase III Randomized Study of First-Line Bevacizumab + Docetaxel in Patients with Human Epidermal Growth Factor Receptor (HER) 2-Negative Metastatic Breast Cancer
Miles, DW, de Haas, SL, Dirix, L, Chan, A, Pivot, X, Tomczak, P, Provencher, L, Delmar, P, Scherer, S.
Published in Cancer research (Chicago, Ill.) (15.12.2010)
Published in Cancer research (Chicago, Ill.) (15.12.2010)
Get full text
Journal Article
High plasma concentrations of human urotensin II do not alter local or systemic hemodynamics in man
Wilkinson, Ian B, Affolter, Jonathan T, de Haas, Sanne L, Pellegrini, M Paola, Boyd, Judith, Winter, Matthew J, Balment, Richard J, Webb, David J
Published in Cardiovascular research (01.02.2002)
Published in Cardiovascular research (01.02.2002)
Get full text
Journal Article